Tom Kurzawinski

Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas

Damian Wild, Emanuel Christ, Martyn Caplin et al. · Journal of Nuclear Medicine · 2011 · 177 citations · Full text

Diagnosis of Duct Disruption and Assessment of Pancreatic Leak with Dynamic Secretin-Stimulated MR Cholangiopancreatography

A. Gillams, Tom Kurzawinski, William R. Lees · American Journal of Roentgenology · 2006 · 146 citations

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

Frédéric Castinetti, Steven G. Waguespack, Andreas Machens et al. · The Lancet Diabetes & Endocrinology · 2019 · 144 citations · Full text

Endocrine Oncology, Medicine, Natural History +8

Phase II Study of Anti–Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer

Bernard Brett, S C L Smith, C. V. Bouvier et al. · Journal of Clinical Oncology · 2002 · 109 citations

Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy

Simon Waller, Tom Kurzawinski, Lewis Spitz et al. · European Journal of Pediatrics · 2004 · 103 citations

Genotype/phenotype Correlation, Neonatal Severe Hyperparathyroidism, Parathyroid Hormone +5